AGIO position history
The shares of Agios Pharmaceuticals (AGIO) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 818,767 shares, $38M, 0.19% of portfolio
- 2021 Q4: 1,256,578 shares, $41M, 0.22% of portfolio, Add +53.5%
- 2022 Q1: 1,333,012 shares, $39M, 0.21% of portfolio, Add +6.1%
- 2022 Q2: 1,333,012 shares, $30M, 0.18% of portfolio
- 2022 Q3: 1,496,829 shares, $42M, 0.25% of portfolio, Add +12.3%
- 2022 Q4: 2,025,829 shares, $57M, 0.37% of portfolio, Add +35.3%
- 2023 Q1: 2,092,829 shares, $48M, 0.27% of portfolio, Add +3.3%
- 2023 Q2: 2,688,829 shares, $76M, 0.43% of portfolio, Add +28.5%
- 2023 Q3: 2,750,829 shares, $68M, 0.34% of portfolio, Add +2.3%
- 2023 Q4: 4,167,602 shares, $93M, 0.46% of portfolio, Add +51.5%
- 2024 Q1: 11,181,204 shares, $327M, 1.5% of portfolio, Add +168.3%
- 2024 Q2: 5,654,502 shares, $244M, 1.2% of portfolio, Reduce −49.4%
- 2024 Q3: 5,660,866 shares, $252M, 1.2% of portfolio, Add +0.1%
- 2024 Q4: 5,674,466 shares, $186M, 0.95% of portfolio, Add +0.2%
- 2025 Q1: 5,700,466 shares, $167M, 0.93% of portfolio, Add +0.5%
- 2025 Q2: 5,767,466 shares, $192M, 0.83% of portfolio, Add +1.2%
- 2025 Q3: 11,562,132 shares, $464M, 1.9% of portfolio, Add +100.5%
- 2025 Q4: 5,159,505 shares, $140M, 0.66% of portfolio, Reduce −55.4%
- 2026 Q1: 5,684,000 shares, $192M, 1.1% of portfolio, Add +10.2%
- 2026 Q2: 5,917,400 shares, $220M, 1.0% of portfolio, Add +4.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|